Platelet Leukocyte Aggregates in Acute Cardiac Syndrome vs Healthy Volunteers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01797016|
Recruitment Status : Completed
First Posted : February 22, 2013
Last Update Posted : November 14, 2014
|Condition or disease|
The goal is to investigate whether there is a simple and inexpensive method to test the level of platelet leukocyte aggregates through the blood count test. The parameters which are obtained routinely for white blood cell counts include: capacity - electrical conductivity (conductivity) - dispersion (scatter), and volume. Though these values are not reported routinely, they can be accessed for each blood count.
The premise is that through blood counts (no need for specialized flow cytometry) and through the parameters mentioned a conclusion can be reached about platelet leukocyte aggregates. This will then aid in prognosis about the risk of an acute event for every patient with ischemic heart disease who comes to the emergency room.
|Study Type :||Observational|
|Actual Enrollment :||59 participants|
|Observational Model:||Case Control|
|Official Title:||Comparing Blood Count Test Measures to Flow Cytometry in Healthy Patients to Acute General Syndrome Patients|
|Study Start Date :||January 2013|
|Actual Primary Completion Date :||September 2014|
|Actual Study Completion Date :||September 2014|
- Detection of platelet-leukocyte aggregates by routine blood count. [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01797016
|Ziv Medical Center|
|Safed, Israel, 13100|
|Principal Investigator:||Nagib Dally, MD||Ziv Medical Center|